224 related articles for article (PubMed ID: 8241801)
1. Inhibitory effects of formoterol on platelet-activating factor induced eosinophil chemotaxis and degranulation.
Eda R; Sugiyama H; Hopp RJ; Okada C; Bewtra AK; Townley RG
Int Arch Allergy Immunol; 1993; 102(4):391-8. PubMed ID: 8241801
[TBL] [Abstract][Full Text] [Related]
2. Effects of PAF, FMLP and opsonized zymosan on the release of ECP, elastase and superoxide from human granulocytes.
Turner NC; Wood LJ; Foster M; Gueremy T
Eur Respir J; 1994 May; 7(5):934-40. PubMed ID: 8050551
[TBL] [Abstract][Full Text] [Related]
3. Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
Soyombo O; Spur BW; Lee TH
Allergy; 1994 Apr; 49(4):230-4. PubMed ID: 8037356
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
Hatzelmann A; Tenor H; Schudt C
Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697
[TBL] [Abstract][Full Text] [Related]
5. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
Eda R; Townley RG; Hopp RJ
Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
[TBL] [Abstract][Full Text] [Related]
6. The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils.
Miyagawa H; Nabe M; Hopp RJ; Okada C; Bewtra AK; Townley G
Agents Actions; 1992 Sep; 37(1-2):39-43. PubMed ID: 1456179
[TBL] [Abstract][Full Text] [Related]
7. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects.
Tenor H; Hatzelmann A; Church MK; Schudt C; Shute JK
Br J Pharmacol; 1996 Aug; 118(7):1727-35. PubMed ID: 8842438
[TBL] [Abstract][Full Text] [Related]
8. Effects of some anti-asthma drugs on human eosinophil superoxide anions release and degranulation.
Ezeamuzie CI; Al-Hage M
Int Arch Allergy Immunol; 1998 Feb; 115(2):162-8. PubMed ID: 9482706
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro.
Alves AC; Pires AL; Cruz HN; Serra MF; Diaz BL; Cordeiro RS; Lagente V; Martins MA
Eur J Pharmacol; 1996 Sep; 312(1):89-96. PubMed ID: 8891583
[TBL] [Abstract][Full Text] [Related]
11. Effect of beta2-adrenergic agonists on eosinophil adhesion, superoxide anion generation, and degranulation.
Noguchi T; Nakagome K; Kobayashi T; Ueda Y; Soma T; Nakamoto H; Nagata M
Allergol Int; 2015 Sep; 64 Suppl():S46-53. PubMed ID: 26344080
[TBL] [Abstract][Full Text] [Related]
12. [Effects of anti-asthmatic drugs on human eosinophil chemotaxis].
Numao T; Fukuda T; Akutsu I; Makino S
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jan; 29(1):65-71. PubMed ID: 1645817
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the release of eosinophil cationic protein by eosinophil adhesion.
Xu X; Håkansson L
Clin Exp Allergy; 2000 Jun; 30(6):794-806. PubMed ID: 10848898
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of pemirolast, a novel antiallergic drug, on leukotriene C4 and granule protein release from human eosinophils.
Kawashima T; Iwamoto I; Nakagawa N; Tomioka H; Yoshida S
Int Arch Allergy Immunol; 1994; 103(4):405-9. PubMed ID: 8130655
[TBL] [Abstract][Full Text] [Related]
15. A novel thromboxane synthetase inhibitor, DP-1904, inhibits human blood eosinophil degranulation.
Agrawal DK; Takami M; Ono S
Inflammation; 1997 Feb; 21(1):1-8. PubMed ID: 9179617
[TBL] [Abstract][Full Text] [Related]
16. Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C.
Egesten A; Malm J
Allergy; 1998 Nov; 53(11):1066-73. PubMed ID: 9860239
[TBL] [Abstract][Full Text] [Related]
17. Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a.
Takafuji S; Tadokoro K; Ito K
Allergy; 1996 Aug; 51(8):563-8. PubMed ID: 8874660
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
Bruijnzeel PL; Warringa RA; Kok PT; Kreukniet J
Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
Whelan CJ; Johnson M; Vardey CJ
Br J Pharmacol; 1993 Oct; 110(2):613-8. PubMed ID: 7902175
[TBL] [Abstract][Full Text] [Related]
20. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro.
Nabe T; Yamamura H; Kohno S
Arzneimittelforschung; 1997 Oct; 47(10):1112-6. PubMed ID: 9368704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
